Trials / Completed
CompletedNCT01890057
The Dose of Sugammadex for Rapid Reversal of Profound Neuromuscular Block in Young and Elderly Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Severance Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To find out the dose of sugammadex for recovery of the TOF ratio to 0.9 within 2 minutes from profound rocuronium-induced neuromuscular block in young and elderly adult patients.
Detailed description
A previous study reported that elderly patients required a longer time to recover from rocuronium induced neuromuscular block compared to younger patients. Therefore, the aim of this study is to find out the dose of sugammadex for rapid recovery from profound neuromuscular block in young and elderly adult patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sugammadex | The dose of sugammadex |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2013-07-01
- Last updated
- 2014-02-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01890057. Inclusion in this directory is not an endorsement.